Novogen Limited (ADR) (NASDAQ:NVGN)

CAPS Rating: 3 out of 5

The Company is a pharmaceutical company involved in the discovery, development, manufacture and marketing of products based on the emerging field of phenolic technology.

Results 1 - 10 of 10

Recs

0
Member Avatar Haugurafpeningum (30.29) Submitted: 1/31/2014 9:36:01 AM : Outperform Start Price: $4.13 NVGN Score: -41.19

z z

Recs

4
Member Avatar zzlangerhans (99.80) Submitted: 12/10/2013 5:07:02 PM : Outperform Start Price: $4.50 NVGN Score: -44.54

Some might snicker at my obsession with this low float Aussie scam but I see it as a money making machine. It remains the only stock I've made money on both long and short, although my returns were substantially impacted by poor timing. I still think Novogen has a lot of funds to redistribute from gullible and novice traders to the smarter and quicker players. Step on up if you think that when the men get separated from the boys, that you'll remain with the former group.

I'm not a technical trader but I believe that Novogen's share price is largely controlled by technical traders, making the technicals self-fulfilling. If you look at the chart since Novogen announced their intention to play rough with wild PR's touting activity of their lead drug against cancer cells in test tubes, the share price never drops much below 4. That seems to be the level at which either management starts issuing goofy PR, or momentum traders start running up the stock. I won't be buying yet with the stock in a downtrend, but I'll start building a new position if it stabilizes below 4.5 or if it drops below 4.

Recs

0
Member Avatar palmeiras (< 20) Submitted: 11/5/2013 12:52:50 AM : Outperform Start Price: $6.18 NVGN Score: -64.92

CS-6 drug shows high potency. Potential partnership announced in letter to shareholders CEO trialed an earlier version of the drug and sent his cancer into remission (that's faith in your product!)

Recs

1
Member Avatar deuspecuniae (95.67) Submitted: 5/1/2008 12:11:16 PM : Outperform Start Price: $190.15 NVGN Score: -144.41

The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical stocks have been beaten down this past winter, and I see a reversal across the entire sector. Also, those companies already on a run will continue due to the upward momentum this summer from key reversals and upgrades throughout the sector.

Recs

0
Member Avatar skytalon1 (< 20) Submitted: 4/22/2008 8:51:37 PM : Outperform Start Price: $207.00 NVGN Score: -146.49

i HAVE NOT DONNE ANY HOMEWORK ON THIS ONE BUT HAVE A GOOD FEELING IT WILL GET HOT IN TIME

Recs

0
Member Avatar Biotech2008 (59.56) Submitted: 1/4/2008 9:58:21 PM : Outperform Start Price: $134.15 NVGN Score: -142.21

applefoot @5.53

Recs

0
Member Avatar tharlow (76.14) Submitted: 11/9/2007 12:04:31 AM : Outperform Start Price: $190.00 NVGN Score: -139.74

Ready to explode.

Recs

0
Member Avatar COOLJOB (< 20) Submitted: 9/23/2007 7:44:43 PM : Outperform Start Price: $200.00 NVGN Score: -133.59

Wish to keep it to myself

Recs

0
Member Avatar Kywong (< 20) Submitted: 6/14/2007 2:35:48 AM : Outperform Start Price: $217.50 NVGN Score: -135.24

The base technology upon which Novogen is basing its work shows plenty of promise as an enabler. I suspect that being a 'toolmaker' for drug developers is a safer proposition than being an out and out drug developer.

Recs

0
Member Avatar LALetal (< 20) Submitted: 2/28/2007 1:09:57 PM : Outperform Start Price: $272.25 NVGN Score: -146.51

Flying under the radar with potenial

Results 1 - 10 of 10

Featured Broker Partners


Advertisement